ReviewJournal of cancer research and clinical oncology2016

Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer.

Dmitri Pchejetski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.